
Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents
Keywords: HCV; Protease inhibitors; Peptidomimetics; Phenylglycine; Resistance; Alkenylic acylsulfonamides;